Test Price
2,800 AED✅ Home Collection Available
FLNB Gene Larsen Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FLNB لمتلازمة لارسن بتقنية التسلسل الجيني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ضمان الدقة: حساسية تشخيصية بنسبة ٩٩.٩٪ عبر معالجة مخبرية معتمدة من ISO.
الخدمات اللوجستية المتميزة: خدمة سحب الدم المنزلي بتقنية التبريد المعتمدة من ISO وجمع العينات عبر الفصد المتنقل الخاص.
الإرشاد السريري: استشارة هاتفية مجانية بعد صدور النتائج لتفسير التحليل.
التأمين: التحقق من التغطية التأمينية عبر واتساب على الرقم +971 54 548 8731.
Overview | نظرة عامة
The FLNB Gene Larsen Syndrome Genetic Test is a comprehensive next-generation sequencing assay that screens for pathogenic variants in the FLNB gene, ensuring precise diagnosis of Larsen syndrome and related dysmorphologies. يقدم هذا التحليل المتكامل تشخيصًا دقيقًا لمتلازمة لارسن من خلال فحص الطفرات الجينية في جين FLNB باستخدام أحدث تقنيات التسلسل الجيني.
| Feature | Our Test (NGS FLNB) | Closest Alternative (Targeted Sanger) |
|---|---|---|
| Precision / Coverage | Full gene sequencing with >99.9% analytical sensitivity; covers all exons and splice sites | Hotspot analysis only; limited to few known mutations |
| Methodology | Next-Generation Sequencing (NGS) with advanced bioinformatics | Sanger sequencing |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks (but incomplete coverage) |
| Clinical Utility | Comprehensive for Larsen syndrome, atelosteogenesis, spondylocarpotarsal synostosis | May miss novel or rare variants |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011): Clinical correlation is paramount; a negative result does not exclude all genetic causes of skeletal dysplasia, and a positive finding confirms predisposition but must be integrated with physical examination and family history. Genetic counseling before and after testing is essential to guide management and recurrence risk.
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active bleeding disorder, recent blood transfusion (within 2 weeks), inability to provide informed consent, or patient younger than 7 days without clinical justification.
- ER Red Flags: Seek immediate emergency care if the patient experiences acute joint dislocation with severe pain, difficulty breathing, stridor, or signs of spinal cord compression (new-onset limb weakness, bowel/bladder dysfunction).
Patient FAQ & Clinical Guidance
What conditions does the FLNB gene test detect? | ما الحالات التي يكشفها التحليل؟
Snippet: This test identifies FLNB gene mutations causing Larsen syndrome and other severe congenital joint dislocations. يحدد هذا التحليل الطفرات الجينية في جين FLNB المسببة لمتلازمة لارسن والتشوهات الهيكلية الخلقية الشديدة. In addition to classic Larsen syndrome (multiple joint dislocations, characteristic facies), the assay can reveal mutations associated with atelosteogenesis types I/III and spondylocarpotarsal synostosis syndrome, enabling targeted orthopedic and multidisciplinary care from infancy.
How is the sample collected, and does the test require any preparation? | كيف يتم جمع العينة وهل يتطلب تحضير مسبق؟
Snippet: A simple blood draw or dried blood spot (FTA card) is collected painlessly by our home phlebotomy team. يمكن جمع العينة بسهولة عن طريق سحب الدم أو بطاقة FTA عبر فريقنا المنزلي المتخصص. No fasting or medication discontinuation is required. A pre-test genetic counseling session is recommended to draw a detailed pedigree; the session can be arranged telephonically prior to sample collection. Our cold-chain logistics guarantee sample integrity from your doorstep to our ISO-certified laboratory.
What does the test result mean and what are the next steps? | ماذا تعني النتيجة وما الخطوات التالية؟
Snippet: A positive result confirms the presence of a disease-causing FLNB mutation and guides targeted orthopedic and genetic care. تؤكد النتيجة الإيجابية وجود طفرة ممرضة في جين FLNB وتوجه الرعاية التقويمية والوراثية الدقيقة. A negative result reduces the likelihood but does not rule out other genetic skeletal dysplasias; further testing (e.g., whole exome sequencing) may be considered. All results are reviewed by a clinical geneticist, and a post- teleconsultation is provided at no extra cost to explain implications for the patient and family.
Regulatory Compliance & Accreditation
This service fully complies with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), the CDS Law 2026 (Minors), and the UAE Personal Data Protection Law (PDPL). All testing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) with DHA facility license 9834453.
Medical coding: ICD-10-CM Q68.8 (Larsen syndrome), Z15.89 (Genetic susceptibility), Z84.89 (Family history). LOINC code: 93341-5 (FLNB gene mutation analysis).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians